Global Flow Cytometry In Oncology And Immunology Market Share 2024, Forecast To 2033
8 Mar, 2024
The flow cytometry in oncology and immunology market has experienced rapid growth, with its size forecasted to rise from $1.89 billion in 2023 to $2.1 billion in 2024, at a CAGR of 10.9%. This growth is fueled by genomics integration and immunotherapy. Looking ahead, the market is anticipated to grow to $3.07 billion by 2028, with a CAGR of 10.0%, driven by expanding applications in infectious diseases and collaborative research initiatives.
Global Flow Cytometry In Oncology And Immunology Market Key Driver
The industrial vehicle market witnesses growth with the growing e-commerce industry, indicated by the International Trade Administration's data on the UK's booming e-commerce revenue.
Get A Free Sample Of The Global Flow Cytometry In Oncology And Immunology Market ReportGlobal Flow Cytometry In Oncology And Immunology Market Segments
The flow cytometry in oncology and immunology market covered in this report is segmented –
1) Type:Immunology, Oncology
2) Technology:Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) Application:Translational Research, Clinical Research
4) End User:Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
By Geography: The countries covered in the flow cytometry in oncology and immunology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the flow cytometry in oncology and immunology market in 2023. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Flow Cytometry In Oncology And Immunology Industry Players
Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Becton Dickinson and Company; Laboratory Corporation of America Holdings; Agilent Technologies Inc.; Sartorius AG; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Sysmex Partec GmbH; OPKO Health Inc.; Miltenyi Biotec; NeoGenomics Laboratories Inc.; Luminex Corporation; Q2 Solutions LLC; Enzi Biochem Inc.; DiaSorin S.p.A;BioLegend Inc.; Cytek Biosciences Inc.; Cell Signaling Technology Inc.; Standard BioTools Inc.; Sony Biotechnology Inc.; NanoCellect Biomedical Inc.; Nexcelom Bioscience LLC; CytoReason.
Get The Full Global Flow Cytometry In Oncology And Immunology Market Report
Flow Cytometry In Oncology And Immunology Market Overview
Flow cytometry in oncology and immunology refers to a technology and method used in oncology and immunology to analyze and characterize cells based on their physical and chemical properties.